NT-proBNP Testing in Patients Presenting to the Emergency Department With Acute Dyspnea: Evaluation of Effects on Treatment, Hospitalisation Rate and Costs

NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24573

Enrollment

477

Registered

2007-04-15

Start date

2004-01-12

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyspnea (dyspnoe)

Interventions

Study-group: Measurement of NT-proBNP plasma level at presentation in the Emergency Department. Control-group: No measurement of NT-proBNP plasma level at presentation in the Emergency Department. Blo

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older; 2. Acute dyspnea as the most prominent complaint

Exclusion criteria

Exclusion criteria: 1. Acute dyspnea due to a trauma; 2. Acute dyspnea due to cardiogenic shock; 3. Renal failure requiring dialysis.

Design outcomes

Primary

Measure	Time frame
1. Time to discharge; 2. Cost of treatment	—

Secondary

Measure	Time frame
1. Duration of stay at the ED; 2. Proportion of patients admitted to the hospital; 3. Proportion of patients admitted to an intensive or coronary care unit; 4. Specialist consultations; 5. Medical treatment; 6. Diagnostic investigations	—

Contacts

Public ContactJ.H.W. Rutten

Erasmus MC

j.rutten@erasmusmc.nl+31 10-4639222

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)